Results 51 to 60 of about 156,476 (227)

Symptomatic iron deficiency anemia from neglected giant basal cell carcinoma [PDF]

JAAD Case Reports, 2020
Leah Laageide, MD, Elizabeth Wendl, MD, Jonathan Wadle, DO, Jennifer Powers, MD   +3 more
doaj   +2 more sources

Giant nodular basal cell skin cancer [PDF]

Vestnik Dermatologii i Venerologii, 2023
The article presents clinical case report of primary giant nodular basal cell skin cancer in two patients at the age of 64 and 68 years and with disease duration of 20 and 15 years respectively. Psychological status of fear and anxiety are considered the
Tatiana G. Sedova, Vladimir D. Elkin
doaj   +1 more source

Giant neglected unresectable ulcerated basal cell carcinoma of face: Radiotherapy at rescue

Journal of Cutaneous and Aesthetic Surgery, 2023
Basal cell carcinomas are typically considered indolent and slowly progressing tumors, but giant basal cell carcinomas are more aggressive with more risk of invasion and poor prognosis.
Shubham Kumar, Suman Patra, Bharti Devnani, Varun Rajagopalan, Maninder Kaur   +4 more
openalex   +2 more sources

Slow‐growing pedunculated nodule

Clinical Case Reports, 2022
There have been limited reported cases of pedunculated basal cell carcinoma(BCC). Our case is original, and it combines two rare aspects of CBC: Pedunculated and giant. This uncommon aspect is rarely encountered.
Chaima Kouki, Nadine Kammoun, Khadija Sellami, Emna Bahloul, Manel Mallouli, Lobna Ayadi, Tahya Boudaouara, Hamida Turki   +7 more
doaj   +1 more source

Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study

Hepatology, EarlyView., 2022
Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study. Abstract Background and Aims Alagille syndrome (ALGS) is a multisystem disorder, characterized by cholestasis. Existing outcome data are largely derived from tertiary centers, and real‐world data are lacking.
Shannon M. Vandriel, Li‐Ting Li, Huiyu She, Jian‐She Wang, Melissa A. Gilbert, Irena Jankowska, Piotr Czubkowski, Dorota Gliwicz‐Miedzińska, Emmanuel M. Gonzales, Emmanuel Jacquemin, Jérôme Bouligand, Nancy B. Spinner, Kathleen M. Loomes, David A. Piccoli, Lorenzo D'Antiga, Emanuele Nicastro, Étienne Sokal, Tanguy Demaret, Noelle H. Ebel, Jeffrey A. Feinstein, Rima Fawaz, Silvia Nastasio, Florence Lacaille, Dominique Debray, Henrik Arnell, Björn Fischler, Susan Siew, Michael Stormon, Saul J. Karpen, Rene Romero, Kyung Mo Kim, Woo Yim Baek, Winita Hardikar, Sahana Shankar, Amin J. Roberts, Helen M. Evans, M. Kyle Jensen, Marianne Kavan, Shikha S. Sundaram, Alexander Chaidez, Palaniswamy Karthikeyan, Maria Camila Sanchez, Maria Lorena Cavalieri, Henkjan J. Verkade, Way Seah Lee, James E. Squires, Christina Hajinicolaou, Chatmanee Lertudomphonwanit, Ryan T. Fischer, Catherine Larson‐Nath, Yael Mozer‐Glassberg, Cigdem Arikan, Henry C. Lin, Jesus Quintero Bernabeu, Seema Alam, Deirdre A. Kelly, Elisa Carvalho, Cristina Targa Ferreira, Giuseppe Indolfi, Ruben E. Quiros‐Tejeira, Pinar Bulut, Pier Luigi Calvo, Zerrin Önal, Pamela L. Valentino, Dev M. Desai, John Eshun, Maria Rogalidou, Antal Dezsőfi, Sabina Wiecek, Gabriella Nebbia, Raquel Borges Pinto, Victorien M. Wolters, María Legarda Tamara, Andréanne N. Zizzo, Jennifer Garcia, Kathleen Schwarz, Marisa Beretta, Thomas Damgaard Sandahl, Carolina Jimenez‐Rivera, Nanda Kerkar, Jernej Brecelj, Quais Mujawar, Nathalie Rock, Cristina Molera Busoms, Wikrom Karnsakul, Eberhard Lurz, Ermelinda Santos‐Silva, Niviann Blondet, Luis Bujanda, Uzma Shah, Richard J. Thompson, Bettina E. Hansen, Binita M. Kamath, The Global ALagille Alliance (GALA) Study Group   +93 more
wiley   +1 more source

TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk

Hepatology, EarlyView., 2022
The systematic approach in elucidating the gain‐of‐function (GOF) roles of TP53 mutations in early liver carcinogenesis. Unique downstream targets of TP53 L3 mutations were identified from chormatin immunoprecipitation sequencing in HCC cell lines, followed by a series of validation assays to substantiate the exclusive transcriptional regulations ...
Yin Kau Lam, Jianqing Yu, Hao Huang, Xiaofan Ding, Alissa M. Wong, Howard H. Leung, Anthony W. Chan, Kelvin K. Ng, Mingjing Xu, Xin Wang, Nathalie Wong   +10 more
wiley   +1 more source

Giant pigmented basal cell carcinoma

Pigment International, 2020
Basal cell carcinoma is a nonmelanocytic skin malignancy, which develops from the basal cells of the skin. More than 80% of BCCs occur on the face, head and neck.
Anupam Das, Abheek Sil
doaj   +1 more source

Vacuum-assisted closure therapy after resection of giant basal cell carcinoma of the scalp. [PDF]

J Surg Case Rep, 2017
Pereira S, Malta W, Canha A, Polónia J.
europepmc   +3 more sources

Giant vulvar basal cell carcinoma [PDF]

BMJ Case Reports, 2013
We report a case of 30-year-old woman presented with giant, foul smelling ulcerated growth involving the vulva. The growth was involving the whole of labia majora, minora and adjacent skin associated with itching, bleeding and discharge (figure 1). The lesion was atypical in its large size and gross morphology.
Satya Narayan Sankhwar, S. C. Gupta, Manish Garg, Pradeep Sharma   +3 more
openaire   +3 more sources

Tumor site immune markers associated with risk for subsequent basal cell carcinomas. [PDF]

, 2011
BackgroundBasal cell carcinoma (BCC) tumors are the most common skin cancer and are highly immunogenic.ObjectiveThe goal of this study was to assess how immune-cell related gene expression in an initial BCC tumor biopsy was related to the appearance of ...
Andridge, Rebecca, Bechtel, Mark A, Chen, Min, De Renne, Lawrence A, Di Gregorio, Michael, Glaser, Ronald, Hearne, Dean W, Herron, Joel Bain, Jewell, Scott D, Johnson, Sheri L, Kiecolt-Glaser, Janice K, Lambert, David R, Shana'ah, Arwa Y, Yang, Eric V   +13 more
core   +5 more sources